Auddia Extends $1.4M Bridge Loan to Merger Targets Ahead of Shareholder Vote

summarizeSummary

Auddia entered bridge notes totaling up to $1.4 million with the four Thramann Holdings subsidiaries it plans to acquire, providing interim funding while the merger is pending and crediting the advances toward its $12 million net cash closing condition.

check_boxKey Events · M&A and Partnerships · AUUD

• Bridge Financing for Merger Targets

  To fund operations while the reverse merger is pending, Auddia entered senior unsecured bridge notes with Thramann Holdings ($360K), LT350 ($400K), Influence Healthcare ($590K), and Voyex ($50K) — up to $1.4 million total.

• Conversion Upside at 20% Discount

  The LT350, Influence, and Voyex notes automatically convert into equity at 80% of the price in a qualified financing ($3M, $2M, and $1M thresholds respectively), giving Auddia a potential equity stake at a discount.

• Cash Credit Preserves Merger Condition

  Funds advanced under the bridge notes are credited toward Auddia's $12 million net cash closing condition, so the loans do not reduce the cash available to satisfy that merger requirement.

• Shareholder Vote in Late August

  The merger still requires Auddia stockholder approval, with a special meeting planned for late August 2026. The bridge notes ensure the targets remain viable through that vote.

auto_awesomeAnalysis · AUUD · Technology

To keep the four private companies it plans to merge with operational while awaiting a late-August shareholder vote, Auddia is lending them up to $1.4 million. The loans are unsecured, carry 8% interest, and for three of the targets convert at a 20% discount if they later raise equity — giving Auddia a potential upside stake. Critically, the cash advanced counts toward Auddia's $12 million net cash merger condition, so this spending doesn't weaken its closing position. The move signals commitment to the merger but also highlights that the targets need cash to survive until the deal closes.